Released on = August 11, 2006, 1:06 pm

Press Release Author = Christy Bowman/GTCbio

Industry = Pharmaceuticals

Press Release Summary = Allen D, Roses, Senior Vice President of Pharmacogenetics
for GlaxoSmithKline, will deliver a presentation entitled, "Translational Genetics -
New Targets and Pharmacogenetic Differentiation of Medicines" on September 18, 2006.


Press Release Body = MONROVIA, CA - Allen D, Roses, Senior Vice President of
Pharmacogenetics for GlaxoSmithKline, will deliver one of three keynote addresses at
the 2nd Therapeutic Strategies against Neurodegenerative Conditions Conference in
Beltsville, MD. Dr. Roses is a renowned expert on genetics research. He joined
GlaxoSmithKline from Duke University in 1997. While at Duke, he led the team that
reported susceptibility association of APOE4 with late-onset Alzheimer disease.

Dr. Roses' presentation entitled, "Translational Genetics - New Targets and
Pharmacogenetic Differentiation of Medicines" will take place at 9:45 am on
September 18, 2006.

The conference will also feature presentations from Acumen, Amgen, Bristol-Myers
Squibb, the Buck Institute for Age Research, Burke-Cornell Medical Research
Institute, The Burnham Institute, Columbia University, CytRx, Elan Pharmaceuticals,
Eli Lilly, EnVivo Pharmaceuticals, Johns Hopkins University, Memory
Pharmaceuticals, Merck Research Laboratories, MGI Pharma, NIH-NIMH, NIH-NINDS,
Neurome Inc., Ottawa Health Research Institute, Pfizer, Santori Pharmaceuticals, the
University of Alabama at Birmingham, the University of British Colulmbia, the
University of North Texas Health Science Center, the University of Rochester School
of Medicine, the University of Texas at Dallas, and Wyeth Research Laboratories.
The full agenda is available online at www.gtcbio.com.

ABOUT GTCbio

GTCbio organizes conferences specifically for the biomedical and biopharmaceutical
industries. Our goal is to facilitate the exchange of biopharmaceutical and
biomedical intelligence between industry leaders, academic and government
organizations, and the financial community.

GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.


Web Site = http://www.gtcbio.com

Contact Details = Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax,
infogtcbio@gtcbio.com